Intermede Investment Partners LTD Bio Rad Laboratories, Inc. Transaction History

Intermede Investment Partners LTD

$4.79 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$524.57 - $735.42 $119 Million - $167 Million	-226,803 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$708.84 - $794.68 $4.7 Million - $5.26 Million	6,625 Added 3.01%	226,803 $171 Million
Q3 2021 Oct 27, 2021	BUY	$657.71 - $825.77 $21.8 Million - $27.4 Million	33,204 Added 17.76%	220,178 $164 Million
Q2 2021 Jul 30, 2021	BUY	$576.64 - $649.04 $29.2 Million - $32.8 Million	50,600 Added 37.1%	186,974 $120 Million
Q1 2021 May 07, 2021	SELL	$547.01 - $662.35 $48.4 Million - $58.6 Million	-88,439 Reduced 39.34%	136,374 $77.9 Million
Q4 2020 Feb 05, 2021	BUY	$510.68 - $643.45 $22.3 Million - $28.1 Million	43,641 Added 24.09%	224,813 $131 Million
Q3 2020 Oct 29, 2020	BUY	$454.43 - $535.6 $2.13 Million - $2.51 Million	4,691 Added 2.66%	181,172 $93.4 Million
Q2 2020 Aug 06, 2020	SELL	$334.87 - $493.06 $13.4 Million - $19.8 Million	-40,057 Reduced 18.5%	176,481 $79.7 Million
Q1 2020 May 11, 2020	SELL	$320.01 - $409.07 $1.17 Million - $1.5 Million	-3,663 Reduced 1.66%	216,538 $75.9 Million
Q4 2019 Feb 10, 2020	BUY	$319.73 - $374.2 $8.12 Million - $9.5 Million	25,391 Added 13.03%	220,201 $81.5 Million
Q3 2019 Nov 01, 2019	BUY	$304.55 - $345.24 $16.3 Million - $18.5 Million	53,569 Added 37.93%	194,810 $64.8 Million
Q2 2019 Jul 30, 2019	BUY	$286.93 - $312.59 $7.19 Million - $7.84 Million	25,066 Added 21.58%	141,241 $44.2 Million
Q1 2019 May 01, 2019	BUY	$224.3 - $317.41 $7.8 Million - $11 Million	34,779 Added 42.73%	116,175 $35.5 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $17.9 Million - $25.2 Million	81,396 New	81,396 $18.9 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.2B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intermede Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Intermede Investment Partners LTD with notifications on news.

Account